Permeability of dopamine D2 receptor agonist hordenine across the intestinal and blood-brain barrier in vitro
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Plos One 17 (2022) 6, e0269486, 1-20
- Ereignis
-
Veröffentlichung
- (wo)
-
Münster
- (wer)
-
Universitäts- und Landesbibliothek Münster
- (wann)
-
2022
- Urheber
-
Hahn, Maria
Lindemann, Viktoria
Behrens, Matthias
Mulac, Dennis
Langer, Klaus
Esselen, Melanie
Humpf, Hans-Ulrich
- DOI
-
10.17879/71099686735
- URN
-
urn:nbn:de:hbz:6-31099735009
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:41 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hahn, Maria
- Lindemann, Viktoria
- Behrens, Matthias
- Mulac, Dennis
- Langer, Klaus
- Esselen, Melanie
- Humpf, Hans-Ulrich
- Universitäts- und Landesbibliothek Münster
Entstanden
- 2022
Ähnliche Objekte (12)
Protease-activated receptor signaling in intestinal permeability regulation
Microglial activation and blood–brain barrier permeability in cerebral small vessel disease
Discriminative learning occasioned by the administration of a dopamine agonist
The impact of bile on intestinal permeability of drug substances
Influence of secretory transporters on the intestinal permeability of cationic drugs
Sphingosine-1-phosphate receptor 4 regulates blood-brain barrier permeability and promotes a homeostatic endothelial phenotype
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?
Assessment of Intestinal Permeability and Inflammation Bio-Markers in Patients with Rheumatoid Arthritis
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Protease-activated receptor signaling in intestinal permeability regulation
Microglial activation and blood–brain barrier permeability in cerebral small vessel disease
Discriminative learning occasioned by the administration of a dopamine agonist
The impact of bile on intestinal permeability of drug substances
Influence of secretory transporters on the intestinal permeability of cationic drugs
Sphingosine-1-phosphate receptor 4 regulates blood-brain barrier permeability and promotes a homeostatic endothelial phenotype
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?
Assessment of Intestinal Permeability and Inflammation Bio-Markers in Patients with Rheumatoid Arthritis
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan
Protease-activated receptor signaling in intestinal permeability regulation
Microglial activation and blood–brain barrier permeability in cerebral small vessel disease
Discriminative learning occasioned by the administration of a dopamine agonist
The impact of bile on intestinal permeability of drug substances
Influence of secretory transporters on the intestinal permeability of cationic drugs
Sphingosine-1-phosphate receptor 4 regulates blood-brain barrier permeability and promotes a homeostatic endothelial phenotype
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?
Assessment of Intestinal Permeability and Inflammation Bio-Markers in Patients with Rheumatoid Arthritis
Enhancement of the intestinal epithelial permeability of peripherally acting opioid analgesics by chitosan